A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Concomitant Administration of Either 23-Valent Pneumococcal Polysaccharide Vaccine or 15-Valent Pneumococcal Conjugate Vaccine

Project: Research project

Project Details

StatusActive
Effective start/end date10/29/21 → 10/28/26

Funding

  • Merck Sharp and Cohme Corporation: $9,250.00